Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1995
09/27/1995EP0673247A1 Fibrinogen receptor antagonists
09/27/1995EP0673234A1 Tissue protective and regenerative compositions
09/27/1995EP0531548B1 Carbostyril derivatives as anti-thrombotic agents
09/27/1995EP0529022B1 New leukotriene b 4? derivatives, method for preparing them and their use as drugs
09/27/1995EP0526535B1 Cyclic hydroxamic acids and their use
09/27/1995EP0462189B1 Combination therapy for treatment of estrogen sensitive diseases
09/27/1995CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
09/27/1995CN1109057A 咪唑并哒嗪 Imidazopyridazine
09/27/1995CN1109056A Imidazopyridines
09/27/1995CN1109055A 4-aminopyrimidine derivatives
09/26/1995US5453533 Enzyme inhibitor
09/26/1995US5453489 Specific amino acid sequences; bind directly to fibronectin, reduces matrix assembly without affecting binding to cells; antitumor/wound healing agents
09/26/1995US5453488 Amino-substituted heterocycles as renin inhibitors
09/26/1995US5453441 Enzyme inhibitors and hypertensive agents
09/26/1995US5453439 Hydroxylamine derivatives
09/26/1995US5453438 Hydroxamic acid based collagenase inhibitors
09/26/1995US5453419 Xenopus laevis bone morphogenetic proteins and use thereof
09/26/1995CA2145476A1 Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals
09/26/1995CA2145475A1 Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals
09/26/1995CA2145473A1 Substituted heterocyclic carboxamidoesters their preparation and their use as pharmaceuticals
09/26/1995CA2145472A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
09/26/1995CA1337128C Propanamine derivatives
09/26/1995CA1337124C Flavolignan derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds
09/26/1995CA1337113C Pharmaceutical composition for eliciting an immunostimulant effect
09/23/1995CA2145027A1 Aminoalkyl benzothiazolinones; process for preparing the same and pharmaceutical compositions containing them
09/23/1995CA2145026A1 Aminoalkyl benzoxazolinones and benzothiazolinones; process for preparing the same and pharmaceutical compositions containing them
09/22/1995CA2145033A1 Cosmetic composition containing a superoxide dismutase and an associated porphyrin
09/21/1995WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b)
09/21/1995WO1995025125A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995WO1995025092A1 Inhibitors of farnesyl-protein transferase
09/21/1995WO1995025091A2 Nipecotic acid derivatives as antithrombic compounds
09/21/1995WO1995025087A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs
09/21/1995WO1995024914A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995WO1995024909A1 Osteoporosis preventing or treating agent
09/21/1995WO1995022974A3 Film coated tablet of paracetamol and domperidone
09/21/1995WO1995021612A3 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
09/21/1995WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
09/21/1995WO1995018826A3 Purified primate ctla-8 antigens and related reagents
09/21/1995DE4408497A1 New bi:phenyl-methyl-benzimidazole derivs.
09/21/1995CA2185553A1 Inhibitors of farnesyl-protein transferase
09/21/1995CA2185341A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995CA2185326A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995CA2163027A1 Nipecotic acid derivatives as antithrombic compounds
09/21/1995CA2162916A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs
09/20/1995EP0672666A2 Imidazodiazepins
09/20/1995EP0672415A1 Organopathy preventing, curing or ameliorating agent
09/20/1995EP0672406A1 Composition based on alpha-pyrones for inducing and stimulating hair growth and/or inhibit loss, and its use
09/20/1995EP0672151A1 Inhibitors of ced-3 and related proteins
09/20/1995EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides
09/20/1995EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
09/20/1995EP0672128A1 Stem cell proliferation factor
09/20/1995EP0672067A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
09/20/1995EP0672064A1 Op-3-induced morphogenesis
09/20/1995EP0672058A1 Calcium channel blocking polypeptides from heteropoda venatoria
09/20/1995EP0672057A1 Analogs of pth
09/20/1995EP0672043A1 Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them
09/20/1995EP0672031A1 Catechol diethers as selective pde iv? inhibitors
09/20/1995EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION
09/20/1995EP0671934A1 Method of treating cell damage or depletion
09/20/1995EP0671922A1 Fluidized intestinal submucosa and its use as an injectable tissue graft
09/20/1995EP0671914A1 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds
09/20/1995EP0671913A1 Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds
09/20/1995EP0671911A1 Carboxy-peptidyl derivatives as antidegenerative active agents
09/20/1995EP0671910A1 Glaucoma treatment
09/20/1995EP0671909A1 Syndecan stimulation of cellular differentiation
09/20/1995EP0364559B1 Substituted adenine derivatives useful as therapeutic agents
09/20/1995CN1108654A Methods of treating menstrual symtoms and compositions therefore
09/20/1995CN1108651A Substituted 1-naphthyl-3-pyrazolecarboxamides which are actie on neurotensin, their preparation and pharmaceutical compositions containing them
09/20/1995CN1029770C Controlled release bases for pharmaceuticals
09/19/1995US5451700 Leukotriene inhibitors
09/19/1995US5451608 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them
09/19/1995US5451606 Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment
09/19/1995US5451603 Side effect reduction
09/19/1995US5451601 Perhydroisoindole derivatives and pharmaceutical compositions containing them
09/19/1995US5451596 Cycloalkyl amine bis-aryl squalene synthase inhibitors
09/19/1995US5451576 Tumor imaging and treatment by water soluble texaphyrin metal complexes
09/19/1995US5451573 Substituted cyclohexane derivatives for the treatment of diseases
09/19/1995US5451518 Purified human ceramide-activated protein kinase
09/19/1995US5451412 Biologically active undenatured whey protein concentrate as food supplement
09/19/1995US5451405 Skin treatment composition
09/19/1995US5451402 Method for killing yeast and sporular microorganisms with haloperoxidase-containing compositions
09/19/1995US5451397 Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels
09/16/1995CA2144556A1 Alpha-pyrones compositions used for inducing and activating the growth of hair and (or) slowing down the loss of hair; use thereof
09/15/1995CA2144374A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
09/14/1995WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof
09/14/1995WO1995024481A2 Humanized monoclonal antibodies against human interleukin-4
09/14/1995WO1995024473A1 Vascular endothelial growth factor 2
09/14/1995WO1995024466A1 Transforming growth factor alpha h1
09/14/1995WO1995024437A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024414A1 Fibroblast growth factor-10
09/14/1995WO1995024411A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995WO1995024393A1 Naphthalene derivatives as prostaglandin i2 agonists
09/14/1995WO1995024391A1 Piperidines and pyrrolidines
09/14/1995WO1995024389A1 Indole derivatives as cck receptor antagonists
09/14/1995WO1995024385A1 Sulphonamide derivatives as aspartyl protease inhibitors
09/14/1995WO1995024381A1 Cyano compounds and preparations thereof
09/14/1995WO1995024379A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
09/14/1995WO1995024213A1 Method of stimulating hematopoiesis with hemoglobin
09/14/1995WO1995024211A1 Use of fibroblast growth factors to stimulate bone growth
1 ... 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 ... 1564